argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
842.00
0.00 (0.00%)
At close: Jan 28, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of $51.87 billion as of January 29, 2026. Its market cap has increased by 30.23% in one year.
Market Cap
51.87B
Enterprise Value
47.92B
Revenue
3.68B
Ranking
n/a
PE Ratio
33.83
Stock Price
$842.00
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 51.87B, an increase of 31,050.49%. That is a compound annual growth rate of 64.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 51.87B | 0.70% |
| Dec 31, 2025 | 51.51B | 37.35% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 460.16M |
| CytoDyn | 310.24M |
| Silence Therapeutics | 236.64M |
| Vaxart | 153.59M |
| HST Global | 131.71M |
| BioStem Technologies | 129.19M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |